- Home
- ZTS vs VTR Comparison
ZTS vs VTR Comparison
Compare ZTS & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZTS | VTR |
|---|---|---|
| Founded | 1952 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.7B | 41.1B |
| IPO Year | 2012 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ZTS | VTR |
|---|---|---|
| Price | $121.63 | $87.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $156.20 | $84.77 |
| AVG Volume (30 Days) | ★ 3.3M | 2.3M |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | 1.74% | ★ 2.36% |
| EPS Growth | 10.05 | ★ 184.21 |
| EPS | ★ 6.02 | 0.54 |
| Revenue | ★ $9,467,000,000.00 | $5,833,980,000.00 |
| Revenue This Year | $5.69 | $12.42 |
| Revenue Next Year | $4.81 | $8.32 |
| P/E Ratio | ★ $20.21 | $162.39 |
| Revenue Growth | 2.28 | ★ 18.47 |
| 52 Week Low | $114.47 | $60.15 |
| 52 Week High | $172.23 | $88.23 |
Technical Indicators
Market Signals| Indicator | ZTS | VTR |
|---|---|---|
| Relative Strength Index (RSI) | 46.41 | 68.36 |
| Support Level | $117.42 | $66.18 |
| Resistance Level | $130.52 | N/A |
| Average True Range (ATR) | 3.20 | 1.41 |
| MACD | -0.75 | -0.13 |
| Stochastic Oscillator | 40.38 | 87.37 |
Price Performance
Historical ComparisonAbout ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.